Partial regression of experimental decompensate cirrhosis after causal agent discontinuation. Vascular characterization and possible therapeutic targets to potentiate regression

Erica Lafoz

IDIBAPS-Hospital Clínic

After graduating in Biomedical Sciences in the University of Barcelona I performed my master degree in Translational Medicine in the same university. Actually I've started my second year of PhD, which I'm performing at IDIBAPS, Barcelona in the hepatic hemodynamic laboratory under Juan Carlos García-Pagán supervision.


Background: Hepatic fibrosis, considered irreversible for many years, is one of the main factors involved in cirrhotic portal hypertension. Experimental and clinical evidence showed that fibrosis can revert. The aim of our... [ view full abstract ]


  1. Erica Lafoz (IDIBAPS-Hospital Clínic)
  2. Marina Vilaseca (IDIBAPS-Hospital Clínic)
  3. Héctor García (IDIBAPS-Hospital Clínic)
  4. Laia Chavarria (IDIBAPS-Hospital Clínic)
  5. Jaume Bosch (IDIBAPS-Hospital Clínic)
  6. Virginia Hernández-gea (IDIBAPS-Hospital Clínic)
  7. Jordi Gracia-Sancho (IDIBAPS-Hospital Clínic)
  8. Joan Carles García-pagán (IDIBAPS-Hospital Clínic)

Topic Area

Liver fibrosis


OS4 » Session 4 Liver Fibrosis - 1 (14:15 - Thursday, 15th June, Aula Maxima, Ground Floor)